A Comparison Between Emerging and Current Biophysical Methods for the Assessment of Higher-Order Structure of Biopharmaceuticals
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 109 (1) , 247-253
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeuticsmAbs, 2018
- MS-based conformation analysis of recombinant proteins in design, optimization and development of biopharmaceuticalsMethods, 2018
- On the Analytical Superiority of 1D NMR for Fingerprinting the Higher Order Structure of Protein Therapeutics Compared to Multidimensional NMR MethodsAnalytical Chemistry, 2015
- Technical Decision-Making with Higher Order Structure Data: Starting a New DialogueJournal of Pharmaceutical Sciences, 2015
- Mapping Monoclonal Antibody Structure by 2D 13C NMR at Natural AbundanceAnalytical Chemistry, 2015
- Profiling Formulated Monoclonal Antibodies by 1H NMR SpectroscopyAnalytical Chemistry, 2013
- Analytical tools for characterizing biopharmaceuticals and the implications for biosimilarsNature Reviews Drug Discovery, 2012
- Structural and Functional Characterization of Disulfide Isoforms of the Human IgG2 SubclassJournal of Biological Chemistry, 2008
- [9] Infrared methods for study of hemoglobin reactions and structures1994
- Determination of amide hydrogen exchange by mass spectrometry: A new tool for protein structure elucidationProtein Science, 1993